Table 2.

Characteristics of T-stage ≤ T2a and low-risk (T-stage ≤ T2a, Gleason score ≤ 6, and PSA level ≤ 10 ng/mL) CaPSURE patients diagnosed after 1994

T-stage ≤ T2a (n = 3,470)Low risk (n = 2,150)
CharacteristicNumber of patientsPercentageNumber of patientsPercentage
Age
 <4010.0310.05
 40–491895.451225.67
 50–591,25636.2085639.82
 60–691,67748.331,00846.88
 70–793449.911637.58
 ≥8030.08
Gleason score
 ≤62,54573.342,150100.00
 773821.27
 ≥81213.49
 Missing661.90
PSA at diagnosis (ng/mL)
 0–2.52035.851627.54
 2.51–4.036210.4328713.35
 4.1–6.01,36939.451,03147.95
 6.1–10.095327.4667031.16
 >10.045113.00
 Missing1323.81